Evaluation of Mortality, Morbidity and Survival of Patients with Esophageal Cancer

Abstract

The only curative treatment for esophageal cancer is surgical resection. This treatment is associated with a high morbidity rate and long in- hospital recovery period. Both Laparoscopic Thoracoscopic and transhiatal esophagectomies are performed worldwide. The aim of this study was to compare the advantages and disadvantages of surgical procedure. Methods: One hundred and eight patients with known esophageal cancers who hospitalized in Sina Hospital and Imam Reza Hospital, Tabriz, between 2015 and 2018, were enrolled the study. Patients were undergone esophagectomy in trans-hital (group A) or laparoscopic thoracoscopic (group B) approach. Survival, mortality and morbidity, including the general and specific complications within 1 month and 6-month and one-year survival of patients were collected from records. Results: There was no significant difference between the two groups in terms of motility 1 and 6 months after surgery and one-year survival (P >0.05). Duration of operation in method A was lower than method B (223.28 ± 33.99 min versus 278.63 ± 33.38 min) (P = 0.001). The duration of hospitalization in the ICU and the ward in the B method was lower (P = 0.001). Complications were higher in the transhital transplantation than in the thoracoscopic laparoscopic method, but this difference was not statistically significant.